Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111).

Zaratin PF, Petrone G, Sbacchi M, Garnier M, Fossati C, Petrillo P, Ronzoni S, Giardina GA, Scheideler MA.

J Pharmacol Exp Ther. 2004 Feb;308(2):454-61. Epub 2003 Oct 30.

PMID:
14593080
2.
3.

Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.

Anzini M, Canullo L, Braile C, Cappelli A, Gallelli A, Vomero S, Menziani MC, De Benedetti PG, Rizzo M, Collina S, Azzolina O, Sbacchi M, Ghelardini C, Galeotti N.

J Med Chem. 2003 Aug 28;46(18):3853-64.

PMID:
12930147
4.

Synthesis and antinociceptive activity of chimonanthines and pyrrolidinoindoline-type alkaloids.

Verotta L, Orsini F, Sbacchi M, Scheildler MA, Amador TA, Elisabetsky E.

Bioorg Med Chem. 2002 Jul;10(7):2133-42.

PMID:
11983509
5.

Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.

Taylor JW, Jin QK, Sbacchi M, Wang L, Belfiore P, Garnier M, Kazantzis A, Kapurniotu A, Zaratin PF, Scheideler MA.

J Med Chem. 2002 Feb 28;45(5):1108-21.

PMID:
11855991
6.
7.

Synthesis and antinociceptive activity of pyrrolidinylnaphthalenes.

Collina S, Azzolina O, Vercesi D, Sbacchi M, Scheideler MA, Barbieri A, Lanza E, Ghislandi V.

Bioorg Med Chem. 2000 Aug;8(8):1925-30.

PMID:
11003137
8.

Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs.

Brooks DP, Valente M, Petrone G, Depalma PD, Sbacchi M, Clarke GD.

J Pharmacol Exp Ther. 1997 Mar;280(3):1176-83.

PMID:
9067301
9.
10.
11.

Selective kappa-opioid agonists: synthesis and structure-activity relationships of piperidines incorporating on oxo-containing acyl group.

Giardina G, Clarke GD, Dondio G, Petrone G, Sbacchi M, Vecchietti V.

J Med Chem. 1994 Oct 14;37(21):3482-91.

PMID:
7932577
12.

Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.

Wang YX, Clarke GD, Sbacchi M, Petrone G, Brooks DP.

J Pharmacol Exp Ther. 1994 Jul;270(1):244-9.

PMID:
8035321
13.

Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.

Brooks DP, Giardina G, Gellai M, Dondio G, Edwards RM, Petrone G, DePalma PD, Sbacchi M, Jugus M, Misiano P, et al.

J Pharmacol Exp Ther. 1993 Jul;266(1):164-71.

PMID:
8392549
14.
15.

Enantiospecificity of kappa receptors: comparison of racemic compounds and active enantiomers in two novel series of kappa agonist analgesics.

Colle R, Clarke GD, Dondio G, Giardina G, Petrone G, Sbacchi M, Vecchietti V.

Chirality. 1992;4(1):8-15.

PMID:
1322687
16.

Characterization of opioid binding sites in rat spinal cord.

Petrillo P, Kowalski J, Sbacchi M, Tavani A.

J Recept Res. 1992;12(1):39-57.

PMID:
1314311
17.
18.

Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.

Tavani A, Petrillo P, La Regina A, Sbacchi M.

J Pharmacol Exp Ther. 1990 Jul;254(1):91-7.

PMID:
2164103
19.

Regional variations in binding capacities at mu-, delta- and kappa-opioid sites in membrane suspensions from rabbit brain.

Petrillo P, La Regina A, Sbacchi M, Tavani A, Robson LE, Kosterlitz HW.

Eur J Pharmacol. 1989 Jul 18;166(2):213-7.

PMID:
2551699
20.
21.
22.

Dopamine denervation of the nucleus accumbens induces a selective increase in the number of delta-opioid binding sites.

Esposito E, Cervo L, Petrillo P, Sbacchi M, Tavani A, Samanin R.

Brain Res. 1987 Dec 8;436(1):25-9.

PMID:
2825926
23.

Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia.

Albizzati MG, Bassi S, Calloni E, Sbacchi M, Piolti R, Frattola L.

Drugs. 1987;33 Suppl 2:90-6.

PMID:
3304956
24.

Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa.

Bassi S, Albizzati MG, Calloni E, Sbacchi M, Frattola L.

Br J Clin Pract. 1986 Jul;40(7):273-5. No abstract available.

PMID:
3741741
25.

The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.

Sbacchi M, La Regina A, Petrillo P, Tavani A.

NIDA Res Monogr. 1986;75:520-3.

PMID:
2828999
26.

Monosialoganglioside therapy in stroke.

Bassi S, Albizzati MG, Sbacchi M, Frattola L, Massarotti M.

Stroke. 1985 Sep-Oct;16(5):899-900. No abstract available.

PMID:
3901426
27.

Motor behaviour modifications after a stroke in a patient with Huntington's disease.

Bassi S, Frattola L, Sbacchi M, Trabucchi M.

J Neurol Neurosurg Psychiatry. 1984 Dec;47(12):1358-9. No abstract available.

28.

Chronic cerebrovascular disorders: a clinical study with cyclandelate.

Bassi S, Albizzati MG, Sbacchi M, Frattola L.

Br J Clin Pract. 1984 Oct;38(10):344-9. No abstract available.

PMID:
6498057
29.

Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders.

Albizzati MG, Bassi S, Sbacchi M, Frattola L.

Br J Clin Pract Suppl. 1984;34:69-73. No abstract available.

PMID:
6430327
30.

Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.

Bassi S, Albizzati MG, Sbacchi M, Frattola L, Massarotti M.

J Neurosci Res. 1984;12(2-3):493-8. No abstract available.

PMID:
6389896
31.

EEG patterns in cerebral tumors with or without edema.

Passerini D, Strambi Ferini L, Sbacchi M, Pezzoli G.

Electromyogr Clin Neurophysiol. 1983 Jan-Feb;23(1-2):117-22. No abstract available.

PMID:
6840032
32.

Lisuride in generalised dystonia and spasmodic torticollis.

Bassi S, Ferrarese C, Frattola L, Sbacchi M, Trabucchi M.

Lancet. 1982 Feb 27;1(8270):514-5. No abstract available.

PMID:
6121171

Supplemental Content

Loading ...
Support Center